메뉴 건너뛰기




Volumn 24, Issue 10, 2006, Pages 1568-1574

Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

EID: 33645745882     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.2200     Document Type: Article
Times cited : (161)

References (41)
  • 2
    • 0038805260 scopus 로고    scopus 로고
    • Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma
    • suppl 1
    • Swerdlow AJ: Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 30:S3-S12, 2003 (suppl 1)
    • (2003) Eur J Nucl Med Mol Imaging , vol.30
    • Swerdlow, A.J.1
  • 3
    • 0347492085 scopus 로고
    • National Cancer Institute
    • National Cancer Institute: SEER Cancer Statistics Review, 1975-2001. http://seer.cancer.gov/csr/1975_2001/
    • (1975) SEER Cancer Statistics Review
  • 4
    • 33750940672 scopus 로고    scopus 로고
    • Late effects after treatment for Hodgkin lymphoma
    • Dembo AJ, Linch DC, Lowenberg B eds, Abingdon, United Kingdom, Taylor & Francis
    • Swerdlow AJ, Van Leeuwen FE: Late effects after treatment for Hodgkin lymphoma, in Dembo AJ, Linch DC, Lowenberg B (eds): Textbook of Malignant Hematology. Abingdon, United Kingdom, Taylor & Francis, 2005, pp 753-768
    • (2005) Textbook of Malignant Hematology , pp. 753-768
    • Swerdlow, A.J.1    Van Leeuwen, F.E.2
  • 5
    • 0022272601 scopus 로고
    • Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82
    • Greene MH, Wilson J: Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:191-217, 1985
    • (1985) Natl Cancer Inst Monogr , vol.68 , pp. 191-217
    • Greene, M.H.1    Wilson, J.2
  • 6
    • 0026081534 scopus 로고
    • Second cancers following non-Hodgkin's lymphoma
    • Travis LB, Curtis RE, Boice JD Jr, et al: Second cancers following non-Hodgkin's lymphoma. Cancer 67:2002-2009, 1991
    • (1991) Cancer , vol.67 , pp. 2002-2009
    • Travis, L.B.1    Curtis, R.E.2    Boice Jr, J.D.3
  • 7
    • 0027361767 scopus 로고
    • Second cancers among long-term survivors of non-Hodgkin's lymphoma
    • Travis LB, Curtis RE, Glimelius B, et al: Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932-1937, 1993
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1932-1937
    • Travis, L.B.1    Curtis, R.E.2    Glimelius, B.3
  • 8
    • 0034057738 scopus 로고    scopus 로고
    • Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia
    • Brennan P, Coates M, Armstrong B, et al: Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 82:1344-1347, 2000
    • (2000) Br J Cancer , vol.82 , pp. 1344-1347
    • Brennan, P.1    Coates, M.2    Armstrong, B.3
  • 9
    • 0035964620 scopus 로고    scopus 로고
    • Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: A search for common mechanisms
    • Dong C, Hemminki K: Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: A search for common mechanisms. Br J Cancer 85:997-1005, 2001
    • (2001) Br J Cancer , vol.85 , pp. 997-1005
    • Dong, C.1    Hemminki, K.2
  • 10
    • 0019518345 scopus 로고
    • Second malignancies in non-Hodgkin's lymphoma
    • MacDougall BK, Weinerman BH, Kemel S: Second malignancies in non-Hodgkin's lymphoma. Cancer 48:1299-1301, 1981
    • (1981) Cancer , vol.48 , pp. 1299-1301
    • MacDougall, B.K.1    Weinerman, B.H.2    Kemel, S.3
  • 11
    • 0022272614 scopus 로고
    • Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80
    • Storm HH, Prener A: Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80. Natl Cancer Inst Monogr 68:389-409, 1985
    • (1985) Natl Cancer Inst Monogr , vol.68 , pp. 389-409
    • Storm, H.H.1    Prener, A.2
  • 12
    • 0025338858 scopus 로고
    • Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas
    • Lavey RS, Eby NL, Prosnitz LR: Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 66:80-88, 1990
    • (1990) Cancer , vol.66 , pp. 80-88
    • Lavey, R.S.1    Eby, N.L.2    Prosnitz, L.R.3
  • 13
    • 0025954879 scopus 로고
    • Second malignant neoplasms in patients with non-Hodgkin's lymphoma
    • Lishner M, Slingerland J, Barr J, et al: Second malignant neoplasms in patients with non-Hodgkin's lymphoma. Hematol Oncol 9:169-179, 1991
    • (1991) Hematol Oncol , vol.9 , pp. 169-179
    • Lishner, M.1    Slingerland, J.2    Barr, J.3
  • 14
    • 10744231424 scopus 로고    scopus 로고
    • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients
    • Andre M, Mounier N, Leleu X, et al: Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood 103:1222-1228, 2004
    • (2004) Blood , vol.103 , pp. 1222-1228
    • Andre, M.1    Mounier, N.2    Leleu, X.3
  • 15
    • 0020522933 scopus 로고
    • Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma
    • Greene MH, Young RC, Merrill JM, et al: Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res 43: 1891-1898, 1983
    • (1983) Cancer Res , vol.43 , pp. 1891-1898
    • Greene, M.H.1    Young, R.C.2    Merrill, J.M.3
  • 16
    • 0021883355 scopus 로고
    • Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas: Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents
    • Pedersen-Bjergaard J, Ersboll J, Sorensen HM, et al: Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas: Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. Ann Intern Med 103:195-200, 1985
    • (1985) Ann Intern Med , vol.103 , pp. 195-200
    • Pedersen-Bjergaard, J.1    Ersboll, J.2    Sorensen, H.M.3
  • 17
    • 0027986943 scopus 로고
    • Risk of leukemia following treatment for non-Hodgkin's lymphoma
    • Travis LB, Curtis RE, Stovall M, et al: Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 86:1450-1457, 1994
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1450-1457
    • Travis, L.B.1    Curtis, R.E.2    Stovall, M.3
  • 18
    • 0030061685 scopus 로고    scopus 로고
    • Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma
    • Travis LB, Weeks J, Curtis RE, et al: Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol 14:565-571, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 565-571
    • Travis, L.B.1    Weeks, J.2    Curtis, R.E.3
  • 19
    • 0036018912 scopus 로고    scopus 로고
    • Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma
    • Hosing C, Munsell M, Yazji S, et al: Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol 13:450-459, 2002
    • (2002) Ann Oncol , vol.13 , pp. 450-459
    • Hosing, C.1    Munsell, M.2    Yazji, S.3
  • 20
    • 0023878162 scopus 로고
    • Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma
    • Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al: Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 318:1028-1032, 1988
    • (1988) N Engl J Med , vol.318 , pp. 1028-1032
    • Pedersen-Bjergaard, J.1    Ersboll, J.2    Hansen, V.L.3
  • 21
    • 0028943553 scopus 로고
    • Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma
    • Travis LB, Curtis RE, Glimelius B, et al: Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87:524-530, 1995
    • (1995) J Natl Cancer Inst , vol.87 , pp. 524-530
    • Travis, L.B.1    Curtis, R.E.2    Glimelius, B.3
  • 22
    • 0026582885 scopus 로고
    • Hodgkin's disease following non-Hodgkin's lymphoma
    • Travis LB, Gonzalez CL, Hankey BF, et al: Hodgkin's disease following non-Hodgkin's lymphoma. Cancer 69:2337-2342, 1992
    • (1992) Cancer , vol.69 , pp. 2337-2342
    • Travis, L.B.1    Gonzalez, C.L.2    Hankey, B.F.3
  • 23
    • 0035476904 scopus 로고    scopus 로고
    • Second malignancy after treatment of childhood non-Hodgkin lymphoma
    • Leung W, Sandlund JT, Hudson MM, et al: Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer 92:1959-1966, 2001
    • (2001) Cancer , vol.92 , pp. 1959-1966
    • Leung, W.1    Sandlund, J.T.2    Hudson, M.M.3
  • 24
    • 0033974306 scopus 로고    scopus 로고
    • Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment
    • Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 498-509
    • Swerdlow, A.J.1    Barber, J.A.2    Hudson, G.V.3
  • 27
    • 33845382806 scopus 로고
    • Non-parametric estimation from incomplete observations
    • Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.1    Meier, P.2
  • 29
    • 3042703949 scopus 로고    scopus 로고
    • Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)
    • Pillon M, Di Tullio MT, Garaventa A, et al: Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Cancer 101:385-394, 2004
    • (2004) Cancer , vol.101 , pp. 385-394
    • Pillon, M.1    Di Tullio, M.T.2    Garaventa, A.3
  • 30
    • 0023101893 scopus 로고
    • Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide
    • Haas JF, Kittelmann B, Mehnert WH, et al: Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 55:213-218, 1987
    • (1987) Br J Cancer , vol.55 , pp. 213-218
    • Haas, J.F.1    Kittelmann, B.2    Mehnert, W.H.3
  • 31
    • 0025023493 scopus 로고
    • Leukemia following chemotherapy for ovarian cancer
    • Kaldor JM, Day NE, Pettersson F, et al: Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1-6, 1990
    • (1990) N Engl J Med , vol.322 , pp. 1-6
    • Kaldor, J.M.1    Day, N.E.2    Pettersson, F.3
  • 32
  • 33
    • 0020458993 scopus 로고
    • Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma
    • Gomez GA, Aggarwal KK, Han T: Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma. Cancer 50:2285-2288, 1982
    • (1982) Cancer , vol.50 , pp. 2285-2288
    • Gomez, G.A.1    Aggarwal, K.K.2    Han, T.3
  • 34
    • 0000849472 scopus 로고    scopus 로고
    • Second cancers
    • DeVita VT, Hellman S, Rosenberg SA eds, Philadelphia, PA, Lippincott Williams & Wilkins
    • Van Leeuwen FE, Travis LB: Second cancers, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott Williams & Wilkins, 2005, pp 2575-2602
    • (2005) Cancer: Principles and Practice of Oncology , pp. 2575-2602
    • Van Leeuwen, F.E.1    Travis, L.B.2
  • 35
    • 0002308237 scopus 로고    scopus 로고
    • Ionizing radiation
    • Schottenfeld D, Fraumeni JF Jr eds, New York, NY, Oxford University Press
    • Boice JD Jr, Land CE, Preston DL: Ionizing radiation, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention. New York, NY, Oxford University Press, 1996, pp 319-354
    • (1996) Cancer Epidemiology and Prevention , pp. 319-354
    • Boice Jr, J.D.1    Land, C.E.2    Preston, D.L.3
  • 36
    • 84871471047 scopus 로고    scopus 로고
    • UNSCEAR: Sources and effects of ionizing radiation. UNSCEAR 2000 Report to the General Assembly, with scientific annexes. New York, NY, United Nations, 2000
    • UNSCEAR: Sources and effects of ionizing radiation. UNSCEAR 2000 Report to the General Assembly, with scientific annexes. New York, NY, United Nations, 2000
  • 37
    • 0035868895 scopus 로고    scopus 로고
    • Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment
    • Swerdlow AJ, Schoemaker MJ, Allerton R, et al: Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment. J Clin Oncol 19:1610-1618, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 1610-1618
    • Swerdlow, A.J.1    Schoemaker, M.J.2    Allerton, R.3
  • 38
    • 0037028736 scopus 로고    scopus 로고
    • Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    • Travis LB, Gospodarowicz M, Curtis RE, et al: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94: 182-192, 2002
    • (2002) J Natl Cancer Inst , vol.94 , pp. 182-192
    • Travis, L.B.1    Gospodarowicz, M.2    Curtis, R.E.3
  • 39
    • 0029021935 scopus 로고
    • Incidence of second cancers in patients treated for Hodgkin's disease
    • Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
    • (1995) J Natl Cancer Inst , vol.87 , pp. 732-741
    • Boivin, J.F.1    Hutchison, G.B.2    Zauber, A.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.